Tengion Appoints Brian Davis as CFO

Tengion, a clinical-stage biotechnology company, has appointed A Brian Davis as chief financial officer (CFO). Davis joins after 15 years with Neose Technologies, a biopharmaceutical company using enzymatic technologies to develop improved protein therapeutics.

Davis advanced from controller to senior vice president (SVP) and CFO at Neose, and brings highly relevant experience to Tengion including raising over US$300m in public and private equity and debt, financial evaluation of business development transactions, treasury and cash management, SEC reporting, Sarbanes-Oxley compliance, and investor relations. Davis holds a BS in Accounting from Trenton State College and an MBA from the Wharton School of the University of Pennsylvania. He is a certified public accountant (CPA).

Linda Hearne, Tengion’s vice president, finance, will be stepping down from her role in order to relocate with her family overseas.


Related reading